In this new research report from Enterprise Strategy Group, learn why organizations without purpose-built, enterprise-grade critical network services experience downsides impacting cloud deployments, security risk and operational agility.

In an age of scaling workloads and immense data generation, the cost of digital space and connectivity in the UK are at a premium as businesses look to grow in line with demand. New forms of compute command low latency, modern networks and reliable technologies, but building out the underlying infrastructure requires significant CapEx and OpEx. This is leading many to look at Cloud and platform based solutions to ensure they can manage workloads and data strategically. This episode will deep dive on a new era of computing environments and examine:

Traditional computing infrastructure faces bottlenecks when managing massive datasets and complex simulations, often delaying critical life science research. Viridien addresses this challenge with its scalable, results-driven "Outcome as a Service" (OaaS) model, offering cloud-based HPC resources tailored to specific research needs. Viridien's model optimises computational workflows, reduces drug discovery timelines, and lowers costs by providing access to advanced simulations and parallel processing capabilities. Researchers benefit from Viridien’s HPC expertise, which improves operational efficiency and enables faster market entry for new drugs. By focusing on achieving specific research outcomes rather than raw computing resources, OaaS minimises hidden costs while delivering measurable results.